Table 1.
Sources of Atrial Tissue and Primary Patient Characteristics
| VARIABLE | LEFT ATRIA | RIGHT ATRIA |
|---|---|---|
|
|
|
|
| Number of specimens | 23 | 28 |
| Gender (male/female) | 19/4 | 20/8 |
| Median age, yrs. | 66 | 61 |
| Surgical Procedures: | ||
| Aortic valve disease | 9 | 13 |
| Aortic valve repair/replacement | (3) | (9) |
| Aortic valve repair/replacement + MAZE | (5) | (3) |
| AVR + MVR | (1) | |
| AVR + MVR + CABG (triple procedure) | (1) | |
| Mitral valve disease | 7 | |
| Mitral valve repair/replacement | (4) | |
| Mitral valve repair/replacement + MAZE | (3) | |
| Ischemic Heart Disease | ||
| CABG only | 7 | 15 |
| CABG + Aortic valve repair/replacement | (5) | (7) |
| CABG + Mitral valve repair/replacement | (1) | (6) |
| CABG +MAZE | (1) | (1) |
| Past Medical History | ||
| Hypertension | 16 | 19 |
| Primary Atrial Fibrillation | 11 | 6 |
| Diabetes mellitus | 4 | 7 |
| Prior Medications | ||
| Angiotensin Converting Enzyme Inhibitors | 8 | 9 |
| Angiotensin II Receptor Blockers | 7 | 6 |
| Aldosterone Antagonists | 1 | |
| Calcium Channel Blockers | 9 | 10 |
| Beta blockers | 15 | 17 |
| Diuretics | 11 | 9 |
| Thiazides | 4 | 3 |
| Furosemide | 7 | 5 |
| Combination | 1 | |
| Statins | 14 | 17 |